Bioceptive
Private Company
Funding information not available
Overview
Bioceptive is an innovative medical device company focused on transforming women's healthcare through pain-reducing, accessible procedural tools. Its lead product, the Cervical Suction Retractor, is a patented, FDA-approved device that replaces the painful tenaculum for cervical stabilization during procedures like IUD insertion. The company is advancing commercialization through a 2025 joint venture with Canadian firm Trimedic and has a foundational history of recognition, including a 2013 Saving Lives at Birth award for its IUD inserter designed for use by non-physician providers.
Technology Platform
Platform for developing single-use, disposable gynecological devices that replace traumatic mechanical tools (like the tenaculum) with gentler alternatives (like suction) to reduce pain, improve safety, and expand procedural access.
Opportunities
Risk Factors
Competitive Landscape
Bioceptive competes against the entrenched standard of care—the metal tenaculum—and other conventional gynecological instruments. While direct competitors with identical suction-retraction technology are not yet prominent, the broader competitive landscape includes large medical device companies (e.g., CooperSurgical, Bayer) that market IUDs and related insertion kits, as well as other startups focused on women's health innovation. Its competitive edge is first-mover advantage with a patented, FDA-approved device that directly addresses a major source of procedural pain.